Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
7.05
+0.22 (3.22%)
At close: Jun 21, 2024, 4:00 PM
7.10
+0.05 (0.71%)
After-hours: Jun 21, 2024, 7:30 PM EDT

Nuvectis Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
2023202220212020
Cash & Equivalents
19.1319.995.740
Cash & Cash Equivalents
19.1319.995.740
Cash Growth
-4.34%248.19%--
Other Current Assets
0.060.410.090
Total Current Assets
19.1920.415.830
Other Long-Term Assets
000.820
Total Long-Term Assets
000.820
Total Assets
19.1920.416.660
Accounts Payable
2.772.911.060.01
Other Current Liabilities
4.213.281.360
Total Current Liabilities
6.986.192.420.01
Total Liabilities
6.986.192.420.01
Retained Earnings
-54.25-31.99-12.9-0.01
Shareholders' Equity
12.214.22-11.01-0.01
Net Cash / Debt
19.1319.995.740
Net Cash / Debt Growth
-4.34%248.19%--
Net Cash Per Share
1.231.581.35-
Working Capital
12.214.223.41-0.01
Book Value Per Share
0.781.12-2.58-0.10
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).